The MUC1 promoter exhibits high transcriptional activity and can drive the expression of genes of interest in adenovirus or plasmid vectors for breast cancer targeted therapy (Gao et al., 2007; Trujillo et al., 2009; Doloff et al., 2011; Tholey et al., 2015). Here, MUC1 is linked to breast cancer.